Good Life Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Good Life Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-468	Closed	-$233K	–	534
2025 Q1	$233K	Buy	468 +10	+2%	+$5.42K	0.02%	446
2024 Q4	$239K	Sell	458 -163	-26%	-$89.6K	0.02%	416
2024 Q3	$384K	Buy	621 +163	+36%	+$96.5K	0.02%	404
2024 Q2	$253K	Buy	458 +7	+2%	+$4.01K	0.02%	389
2024 Q1	$262K	Buy	451 +5	+1%	+$2.81K	0.02%	376
2023 Q4	$237K	Hold	446	–	–	0.02%	376
2023 Q3	$226K	Buy	446 +43	+11%	+$22.9K	0.03%	361
2023 Q2	$210K	Sell	403 -30	-7%	-$16.2K	0.02%	370
2023 Q1	$250K	Sell	433 -39	-8%	-$22K	0.03%	327
2022 Q4	$260K	Sell	472 -105	-18%	-$55.6K	0.04%	292
2022 Q3	$293K	Buy	577 +55	+11%	+$30.8K	0.04%	256
2022 Q2	$284K	Buy	522 +52	+11%	+$28.6K	0.04%	268
2022 Q1	$278K	Hold	470	–	–	0.03%	300
2021 Q4	$314K	Sell	470 -34	-7%	-$21.2K	0.04%	280
2021 Q3	$288K	Sell	504 -5	-1%	-$2.74K	0.04%	275
2021 Q2	$257K	Sell	509 -27	-5%	-$12.7K	0.05%	253
2021 Q1	$243K	Buy	536 +73	+16%	+$34.8K	0.05%	252
2020 Q4	$217K	Buy	+463	New	+$217K	0.05%	239

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Good Life Advisors's TMO Position: Q2 2025 in Review

Good Life Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 468 shares — an estimated $233K sold.

Good Life Advisors first reported a position in TMO in Q4 2020 and held it in 18 quarters. The position peaked at $384K in Q3 2024. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Good Life Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Good Life Advisors sold 468 Thermo Fisher Scientific shares in Q2 2025, an estimated $233K.
Good Life Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 18 quarters.
Good Life Advisors's Thermo Fisher Scientific position peaked at $384K in Q3 2024.
2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.